rs151344492
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000397.4(CYBB):c.1637T>C(p.Leu546Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Publications
- granulomatous disease, chronic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- chronic granulomatous diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiencyInheritance: XL, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYBB | NM_000397.4 | c.1637T>C | p.Leu546Pro | missense_variant | Exon 13 of 13 | ENST00000378588.5 | NP_000388.2 | |
| CYBB | XM_047441855.1 | c.1331T>C | p.Leu444Pro | missense_variant | Exon 12 of 12 | XP_047297811.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYBB | ENST00000378588.5 | c.1637T>C | p.Leu546Pro | missense_variant | Exon 13 of 13 | 1 | NM_000397.4 | ENSP00000367851.4 | ||
| ENSG00000250349 | ENST00000465127.1 | c.171+384841T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
- -
Published functional studies demonstrate a damaging effect: p.(L546P) significantly reduces oxidase and diaphorase activity and inhibits phox translocation (PMID: 20724480); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35796921, 21604087, 20724480, 34175765, 10089913) -
Granulomatous disease, chronic, X-linked Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 546 of the CYBB protein (p.Leu546Pro). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Leu546 amino acid residue in CYBB. Other variant(s) that disrupt this residue have been observed in individuals with CYBB-related conditions (PMID: 10089913, 21604087), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CYBB protein function. ClinVar contains an entry for this variant (Variation ID: 68389). This missense change has been observed in individual(s) with chronic granulomatous disease (PMID: 10089913). This variant is not present in population databases (gnomAD no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at